Long-term treatment strategies may be needed to sustain weight loss These considerations underscore the importance of a flexible, individualized approach to weight management when using GLP-1RAs
This data point is notable for two reasons: It suggests that oral GLP-1 receptor activation can sustain metabolic effects achieved by injectable therapy It addresses a real-world concern regarding treatment transitions, which are common due to availability, cost, or patient preference Importantly, Lilly did not claim superiority over semaglutide
It can also be significantly impacted by social, economic, and environmental challenges that individuals may face like limited health education, financial constraints, and lack of social support
A., Burlacu, A
While there is no definitive evidence that GLP-1 receptor agonists worsen arrhythmia control, the additional heart rate increase could theoretically affect symptoms or ventricular rate control in susceptible individuals
